ArticleInternational journal of clinical practice2021

Comparing cost of intravenous infusion and subcutaneous biologics in COVID-19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey.

Adrian Heald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.